4.4 Article

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals

Jasper van der Lugt et al.

ANTIVIRAL THERAPY (2009)

Review Pharmacology & Pharmacy

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women

Matthieu Roustit et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Article Immunology

Lopinavir Exposure With an Increased Dose During Pregnancy

Mark Mirochnick et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)

Article Immunology

Reduced lopinavir exposure during pregnancy

Alice M. Stek et al.

Review Pharmacology & Pharmacy

Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach

GD Anderson

CLINICAL PHARMACOKINETICS (2005)

Article Immunology

Evaluation of antiretroviral drug measurements by an interlaboratory quality control program

JAH Droste et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)

Article Obstetrics & Gynecology

Physiologic changes in pregnancy and their effect on drug disposition

MC Frederiksen

SEMINARS IN PERINATOLOGY (2001)